MedPath

The Impact of Surgical Treatment of Endometriomas on Ovarian Reserve

Not Applicable
Conditions
Endometriosis
Registration Number
NCT01425333
Lead Sponsor
Saad Amer
Brief Summary

The aim of this study is to assess which of two commonly used surgical procedures in the treatment of ovarian cysts called endometriomas (cutting out of the cyst - "cystectomy", or draining it and cauterising it's inner lining - "ablation") causes the least damage to the ovary and is therefore best at maintaining the future fertility potential of a patient.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
20
Inclusion Criteria
  • Women undergoing laparoscopic surgery for treatment of unilateral endometriomas measuring ≥ 3cm and ≤ 8cm in diameter
Exclusion Criteria
  • Patients who have received oestrogen suppressing drugs (e.g. oral contraceptive pills, GnRHa) during the previous six months
  • Patients who have previously undergone surgical treatment of endometriomas
  • Patients with bilateral endometriomas
  • Patients with endometriomas of less than 3cm in size or more than 8cm in size
  • Pre-surgical evidence of reduced ovarian reserve
  • Pregnant patients
  • Patients unable to give informed consent e.g. patients with mental incapacity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Anti-Mullerian Hormone (AMH)6 months post-operatively

Change in anti-mullerian hormone level after surgery (at one week, three months and six months)

Secondary Outcome Measures
NameTimeMethod
Follicle Stimulating Hormone (FSH)6 months

Change in follicle stimulating hormone levels after surgery (at one week, three months and six months)

Antral Follicle Count (AFC)3 months

Change in AFC after surgery (at three months)

Trial Locations

Locations (1)

Royal Derby Hospital

🇬🇧

Derby, United Kingdom

Royal Derby Hospital
🇬🇧Derby, United Kingdom
Saad Amer, MD, MRCOG
Contact
+44(1332)724612
saad.amer@nottingham.ac.uk
Francesca Raffi, MBChB, MRCOG
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.